Melanoma News and Research

Latest Melanoma News and Research

New drug shows promise in killing cancer cells with genetic vulnerability

Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.

1 Nov 2023

The sunscreen paradox: individuals with higher levels of sun exposure use more but not an adequate quantity of sunscreen

Researchers investigated the variables contributing to the varying frequency of melanoma in the Atlantic provinces of Canada to improve understanding of participants' attitudes toward exposure to the sun and inform public health guidelines related to CM prevention.

31 Oct 2023

Rise in skin cancer cases underscores importance of early detection using machine learning

Image-processing techniques in machine learning (ML) for skin cancer detection using clinical images.

30 Oct 2023

Study highlights a “sunscreen paradox” and the false sense of security against skin cancer

Sunscreen usage is climbing, but so are melanoma and skin cancer rates: this, researchers say, is the sunscreen paradox.

27 Oct 2023

AI-assisted smartphone app performs well in skin cancer diagnosis

Artificial intelligence (AI) is already widely used in medical diagnostics. An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna investigated the extent to which diagnosis and therapy of pigmented skin lesions benefit from it in a realistic clinical scenario.

24 Oct 2023

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.

24 Oct 2023

"Two-for-one" cancer immunotherapy more effective and at least as safe as standard treatments

A "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an international, early-phase clinical trial report today in the journal Nature Medicine.

19 Oct 2023

Researchers develop experimental vaccine to prevent spread of metastatic cancers to the lungs

Engineers at the University of California San Diego have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs.

18 Oct 2023

Research suggests a potential new approach for halting the spread of pancreatic cancer

A new study carried out in mice, led by Queen Mary University of London, has identified cells that drive the spread of pancreatic cancer and discovered a weakness in these cells that could be targeted using existing drugs.

18 Oct 2023

Does inflammatory bowel disease have a causal relationship with extracolonic tumors?

Whether inflammatory bowel disease (IBD) is causally related to extracolonic cancers.

17 Oct 2023

Smart scalpels could pave the way for surgeries performed by robotic devices

Scalpels with built-in sensors could streamline training for surgeons and pave the way for procedures performed by robotic devices, a study suggests.

12 Oct 2023

New AI software achieves 100% detection rate for melanoma

Skin cancer detection using artificial intelligence (AI) software has rapidly improved, new research has shown, with the latest software reaching a 100% detection rate for melanoma.

11 Oct 2023

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year.

11 Oct 2023

New nanocapsule treatment boosts immune response against solid tumors

UCLA researchers have developed a new treatment method using a tiny nanocapsule to help boost the immune response, making it easier for the immune system to fight and kill solid tumors.

11 Oct 2023

Non-melanoma skin cancer causing greater number of global deaths than melanoma, study finds

Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the European Academy of Dermatology and Venerology (EADV) Congress 2023 has found.

10 Oct 2023

Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of Texas at Austin has found.

9 Oct 2023

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Challenges associated with the development and design of neoantigen cancer vaccines.

5 Oct 2023

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma.

4 Oct 2023

Is ChatGPT ready to be your next medical advisor?

Vanderbilt University researchers explored ChatGPT's potential in medical information provision to professionals and patients. While showing promise in delivering accurate, comprehensive medical insights, the need for continuous algorithm refinement and better source discernment were highlighted to fully harness ChatGPT's potential.

3 Oct 2023

Gene variants linked to higher risk for nodular melanoma identified

Researchers from The University of Queensland and The Alfred hospital in Melbourne have identified gene variants which may contribute to people being at higher risk for nodular melanoma.

3 Oct 2023

Melanoma News and Research

Latest Melanoma News and Research

New drug shows promise in killing cancer cells with genetic vulnerability

The sunscreen paradox: individuals with higher levels of sun exposure use more but not an adequate quantity of sunscreen

Rise in skin cancer cases underscores importance of early detection using machine learning

Study highlights a “sunscreen paradox” and the false sense of security against skin cancer

AI-assisted smartphone app performs well in skin cancer diagnosis

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

"Two-for-one" cancer immunotherapy more effective and at least as safe as standard treatments

Researchers develop experimental vaccine to prevent spread of metastatic cancers to the lungs

Research suggests a potential new approach for halting the spread of pancreatic cancer

Does inflammatory bowel disease have a causal relationship with extracolonic tumors?

Smart scalpels could pave the way for surgeries performed by robotic devices

New AI software achieves 100% detection rate for melanoma

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

New nanocapsule treatment boosts immune response against solid tumors

Non-melanoma skin cancer causing greater number of global deaths than melanoma, study finds

Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

Is ChatGPT ready to be your next medical advisor?

Gene variants linked to higher risk for nodular melanoma identified

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Melanoma News and Research

Latest Melanoma News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in